JAMDA
Volume 3, Issue 3 , Pages 146-151 , May 2002

Characterizing Behavioral and Psychological Symptoms of Dementia (BPSD) Among Geropsychiatric Inpatients

  • Sandra L. Tunis, PhD

      Affiliations

    • Lilly Research Laboratories, Indianapolis, Indiana
    • Corresponding Author InformationCorrespondence should be addressed to Sandra L. Tunis, PhD, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285
    • ,
  • William S. Edell, PhD

      Affiliations

    • Mental Health Outcomes, Lewisville, Texas
    • ,
  • Bryan E. Adams, PhD

      Affiliations

    • Mental Health Outcomes, Lewisville, Texas
    • ,
  • John S. Kennedy, MD

      Affiliations

    • Lilly Research Laboratories, Indianapolis, Indiana

References 

  1. Walker M, Salek S, Bayer A. A review of quality-of-life in Alzheimer's Disease Part I: Issues in assessing disease impact. Pharmacoeconomics. 1998;14:499–530
  2. Mintzer J, Hoernig K, Mirski D. Treatment of agitation in patients with dementia. Clin Geriatr Med. 1998;14:147–175
  3. Rabins PV, Mace NL, Lucas MJ. The impact of dementia on the family. JAMA. 1982;248:333–335
  4. Lopez O, Wisniewski S, Becker J, et al. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer's Disease. Arch Neurol. 1999;56:1266–1272
  5. Blume L, Persely N, Mintzer J. The prevalence of dementia: The confusion of numbers. Am J Alzheimer's Care Related Disord Res. 1992;3:3–18
  6. Lieberman M, Kramer J. Factors affecting decisions to institutionalize demented elderly. Gerontologist. 1991;31:371–374
  7. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990;147:1049–1051
  8. Lyketsos CG, Steele C, Galik E, et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry. 1999;156:66–71
  9. Mega M, Cummings J, Fiovello T, Gornbein J. The spectrum of behavioral change in Alzheimer's disease. Neurology. 1996;46:130–135
  10. Dyck G. Management of geriatric behavior problems. Psychiatr Clin North Am. 1997;20:165–180
  11. Morriss RK, Rovner BW, German PS. Factors contributing to nursing home admission because of disruptive behavior. Int J Geriatr Psychiatry. 1996;11:243–249
  12. National Center for Health Statistics. The National Nursing Home Survey. Summary for the United States. Vital and Health Statistics. Series 13, No 97 DHHS Publication No. PHS 89-1758. Washington, DC: U.S. Government Printing Office, 1989, 1985.
  13. Meek P, McKeithan K, Schumock G. Economic Considerations in Alzheimer's Disease. Pharmacotherapy. 1998;18:68S–73S
  14. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  15. Morriss RK, Rovner BW, German PS. Clinical and psychosocial variables associated with different types of behaviour problems in new nursing home admissions. Int J Geriatr Psychiatry. 1995;10:547–555
  16. Wilkinson IM, Graham-White J. Psychogeriatric Dependency Rating Scale (PGDRS): A method of assessment for use by nurses. Br J Psychiatry. 1980;137:558–565
  17. American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC, 1994.
  18. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922–935
  19. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatric Res. 1983;17:37–49
  20. Nitcher RL, Burke WJ, Roccaforte WH, Wengel SP. A collateral source version of the Geriatric Depression Rating Scale. Am J Geriatr Psychiatry. 1993;1:143–152
  21. Wilkinson I, Zissler LM. Standardised assessments for the elderly: Clinical applications. Nursing Times. 1984;80:36–37
  22. Rovner BW, Kafonek S, Filipp L, Lucas MJ, Folstein MF. Prevalence of mental illness in a community nursing home. Am J Psychiatry. 1986;143:1446–1449
  23. German PS, Rovner BW, Burton LC, Brant LJ, Clark R. The role of mental morbidity in the nursing home experience. Gerontologist. 1992;32:152–158
  24. Morriss RK, Rovner BW, German PS. Changes in behaviour before and after nursing home admission. Int J Geriatr Psychiatry. 1994;9:965–973
  25. Answer Tree™ 2.0 Users’ Guide, SPSS Inc. Chicago, Illinois; 1998.
  26. Crum R, Anthony JC, Bassett SS, Folstein MF. Population Based Norms for the Mini-Mental State Examination by Age and Education Level. JAMA. 1993;269:2386–2391
  27. Martino-Saltzman D, Blasch B, Morris R, McNeal L. Travel behavior of nursing home residents perceived as wanderers and nonwanderers. Gerontologist. 1991;31:666–672
  28. Hamel M, Gold D, Andres D, et al. Predictors and consequences of aggressive behaviour by community-based dementia patients. Gerontologist. 1990;30:206–211
  29. Small GW. Psychopharmacological treatment of elderly demented patients. J Clin Psychiatry. 1988;49:8–13
  30. Tariot PN. Treatment strategies for agitation and psychosis in dementia. J Clin Psychiatry. 1996;57:21–29
  31. Maixner SM, Mellow AM, Tandon R. The efficacy, safety, and tolerability of antipsychotics in the elderly. J Clin Psychiatry. 1999;60:29–41
  32. Kumar V, Brecher M. Psychopharmacology of atypical antipsychotics and clinical outcomes in elderly patients. J Clin Psychiatry. 1999;60:5–9
  33. Zarate CA, Baldessarini RJ, Siegel AJ, et al. Risperidone in the elderly: A pharmacoepidemiologic study. J Clin Psychiatry. 1997;58:311–317
  34. Irizarry MC, Ghaemi SN, Lee-Cherry ER, et al. Risperidone treatment of behavioral disturbances in outpatients with dementia. J Neuropsychiatry Clin Neurosci. 1999;11:336–342
  35. Madhusoodanan S, Suresh P, Brenner R, Pillai R. Experience with the atypical antipsychotics-risperidone and olanzapine in the elderly. Ann Clin Psychiatry. 1999;11:113–118
  36. Street J, Clark WS, Mitan S, et al. Olanzapine in the treatment of psychiatric disturbances associated with Alzheimer's disease. Neurology. 1999;52:396–397
  37. Davidson M, Weiser M, Soares K. Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: A meta-analysis of randomized controlled clinical trials. Int Psychogeriatr. 2000;12:271–277
  38. DeDeyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PLJ, Eriksson S, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology. 1999;53:946–955
  39. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. J Clin Psychiatry. 1999;60:107–115
  40. Edell W, Tunis S. Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Geropsychiatric Inpatients. Am J Geriatr Psychiatry. 2001;9:289–297
  41. Cummings JL, Jeste DV. Alzheimer's disease and its management in the year 2010. Psychiatr Serv. 1999;50:1173–1177

 This research was funded by Eli Lilly and Company, Indianapolis, Indiana.Portions of the work were presented in poster format at the 2001 Annual Symposium of the American Medical Directors Association, Atlanta, Georgia, March 15–18, 2001.

PII: S1525-8610(04)70457-0

doi: 10.1016/S1525-8610(04)70457-0

JAMDA
Volume 3, Issue 3 , Pages 146-151 , May 2002

Article Tools